Ledger.Open graph →
SEC Form D · Amendment · filed September 17, 2025

Nexo Therapeutics, Inc

Offering
$60.0M
Sold
$52.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LITTLETON, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Carlo Rizzuto · Littleton, CODirectorAli Behbahani · Littleton, CODirectorAndrew Phillips · Littleton, COExec · DirectorSteven Pennock · Scottsdale, AZDirectorScott Carita · Wilmington, DEExec · DirectorCharles I. Smith · Little Rock, ARDirectorWalter Raquet · Warba, MNDirectorManish Thakur · New York, NYExec · DirectorRichard A. Smith, Jr · Manhattan Beach, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗